219 related articles for article (PubMed ID: 30427110)
1. A feared combination: Hypertension and chronic kidney disease.
Varleta P; Tagle R
J Clin Hypertens (Greenwich); 2019 Jan; 21(1):102-104. PubMed ID: 30427110
[No Abstract] [Full Text] [Related]
2. Antihypertensive therapy prescribing patterns and correlates of blood pressure control among hypertensive patients with chronic kidney disease.
Magvanjav O; Cooper-DeHoff RM; McDonough CW; Gong Y; Segal MS; Hogan WR; Johnson JA
J Clin Hypertens (Greenwich); 2019 Jan; 21(1):91-101. PubMed ID: 30427124
[TBL] [Abstract][Full Text] [Related]
3. Arterial hypertension and proteinuria in pediatric chronic kidney disease.
Simonetti GD; Bucher BS; Tschumi S; Lava SA; Bianchetti MG
Minerva Pediatr; 2012 Apr; 64(2):171-82. PubMed ID: 22495191
[TBL] [Abstract][Full Text] [Related]
4. Use of Antihypertensive Agents and Association With Risk of Adverse Outcomes in Chronic Kidney Disease: Focus on Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers.
Ku E; McCulloch CE; Vittinghoff E; Lin F; Johansen KL
J Am Heart Assoc; 2018 Oct; 7(19):e009992. PubMed ID: 30371331
[TBL] [Abstract][Full Text] [Related]
5. Acute kidney injury is a risk factor for subsequent proteinuria.
Parr SK; Matheny ME; Abdel-Kader K; Greevy RA; Bian A; Fly J; Chen G; Speroff T; Hung AM; Ikizler TA; Siew ED
Kidney Int; 2018 Feb; 93(2):460-469. PubMed ID: 28927644
[TBL] [Abstract][Full Text] [Related]
6. Change in proteinuria after adding aldosterone blockers to ACE inhibitors or angiotensin receptor blockers in CKD: a systematic review.
Bomback AS; Kshirsagar AV; Amamoo MA; Klemmer PJ
Am J Kidney Dis; 2008 Feb; 51(2):199-211. PubMed ID: 18215698
[TBL] [Abstract][Full Text] [Related]
7. The angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic kidney disease.
Yanagi M; Tamura K; Fujikawa T; Wakui H; Kanaoka T; Ohsawa M; Azushima K; Maeda A; Kobori H; Umemura S
Hypertens Res; 2013 Mar; 36(3):262-9. PubMed ID: 23154587
[TBL] [Abstract][Full Text] [Related]
8. Renal protection in hypertensive patients: selection of antihypertensive therapy.
Wenzel RR
Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
[TBL] [Abstract][Full Text] [Related]
9. Utilization patterns of antihypertensive drugs among the chronic kidney disease population in the United States: a cross-sectional analysis of the national health and nutrition examination survey.
Sonawane KB; Qian J; Hansen RA
Clin Ther; 2015 Jan; 37(1):188-96. PubMed ID: 25524390
[TBL] [Abstract][Full Text] [Related]
10. Dual renin-angiotensin system blockade for nephroprotection.
Ruggenenti P
Nephrol Ther; 2017 Apr; 13 Suppl 1():S43-S45. PubMed ID: 28577742
[TBL] [Abstract][Full Text] [Related]
11. Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis.
Currie G; Taylor AH; Fujita T; Ohtsu H; Lindhardt M; Rossing P; Boesby L; Edwards NC; Ferro CJ; Townend JN; van den Meiracker AH; Saklayen MG; Oveisi S; Jardine AG; Delles C; Preiss DJ; Mark PB
BMC Nephrol; 2016 Sep; 17(1):127. PubMed ID: 27609359
[TBL] [Abstract][Full Text] [Related]
12. Role of combination therapy with ACE inhibitors and calcium channel blockers in renal protection.
Locatelli F; Del Vecchio L; Andrulli S; Colzani S
Kidney Int Suppl; 2002 Dec; (82):S53-60. PubMed ID: 12410856
[TBL] [Abstract][Full Text] [Related]
13. Addition of vitamin D reverses the decline in GFR following treatment with ACE inhibitors/angiotensin receptor blockers in patients with chronic kidney disease.
Soares AE; Maes M; Godeny P; Matsumoto AK; Barbosa DS; da Silva TAF; Souza FHMO; Delfino VDA
Life Sci; 2017 Dec; 191():175-179. PubMed ID: 29079468
[TBL] [Abstract][Full Text] [Related]
14. Considerable international variation exists in blood pressure control and antihypertensive prescription patterns in chronic kidney disease.
Alencar de Pinho N; Levin A; Fukagawa M; Hoy WE; Pecoits-Filho R; Reichel H; Robinson B; Kitiyakara C; Wang J; Eckardt KU; Jha V; Oh KH; Sola L; Eder S; de Borst M; Taal M; Feldman HI; Stengel B;
Kidney Int; 2019 Oct; 96(4):983-994. PubMed ID: 31358344
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic advantage of angiotensin-converting enzyme inhibitors in patients with proteinuric chronic kidney disease.
Omae K; Ogawa T; Nitta K
Heart Vessels; 2010 May; 25(3):203-8. PubMed ID: 20512447
[TBL] [Abstract][Full Text] [Related]
16. Blood-pressure control and delay in progression of kidney disease in children.
Ingelfinger JR
N Engl J Med; 2009 Oct; 361(17):1701-3. PubMed ID: 19846857
[No Abstract] [Full Text] [Related]
17. Strict blood-pressure control and progression of renal failure in children.
; Wühl E; Trivelli A; Picca S; Litwin M; Peco-Antic A; Zurowska A; Testa S; Jankauskiene A; Emre S; Caldas-Afonso A; Anarat A; Niaudet P; Mir S; Bakkaloglu A; Enke B; Montini G; Wingen AM; Sallay P; Jeck N; Berg U; Caliskan S; Wygoda S; Hohbach-Hohenfellner K; Dusek J; Urasinski T; Arbeiter K; Neuhaus T; Gellermann J; Drozdz D; Fischbach M; Möller K; Wigger M; Peruzzi L; Mehls O; Schaefer F
N Engl J Med; 2009 Oct; 361(17):1639-50. PubMed ID: 19846849
[TBL] [Abstract][Full Text] [Related]
18. PAIT-Survey Follow-Up: Changes in Albuminuria in Hypertensive Diabetic Patients with Mild-Moderate Chronic Kidney Disease.
Fici F; Ari Bakir E; Ilkay Yüce E; Kanuncu S; Makel W; Tarim BA; Robles NR
High Blood Press Cardiovasc Prev; 2020 Feb; 27(1):43-49. PubMed ID: 31916208
[TBL] [Abstract][Full Text] [Related]
19. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.
Wright JT; Bakris G; Greene T; Agodoa LY; Appel LJ; Charleston J; Cheek D; Douglas-Baltimore JG; Gassman J; Glassock R; Hebert L; Jamerson K; Lewis J; Phillips RA; Toto RD; Middleton JP; Rostand SG;
JAMA; 2002 Nov; 288(19):2421-31. PubMed ID: 12435255
[TBL] [Abstract][Full Text] [Related]
20. Pentoxifylline plus ACEIs/ARBs for proteinuria and kidney function in chronic kidney disease: a meta-analysis.
Liu D; Wang LN; Li HX; Huang P; Qu LB; Chen FY
J Int Med Res; 2017 Apr; 45(2):383-398. PubMed ID: 28415944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
